Inhibition of Janus kinase/signal transducer and activator of transcription (JAK/STAT) signalling pathway in rheumatoid synovial fibroblasts using small molecule compounds

Janus kinase (JAK) inhibitors have been developed as anti-inflammatory agents and have demonstrated clinical efficacy in rheumatoid arthritis (RA). We investigated if JAK-3-selective inhibition alone could disrupt cytokine signalling in rheumatoid synovial fibroblasts. In-vitro studies were performe...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Migita, K, Izumi, Y, Torigoshi, T, Satomura, K, Izumi, M, Nishino, Y, Jiuchi, Y, Nakamura, M, Kozuru, H, Nonaka, F, Eguchi, K, Kawakami, A, Motokawa, S
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Science Inc 2013
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3826302/
https://ncbi.nlm.nih.gov/pubmed/23968543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.12190
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items